Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for MRUS

Stock NameMerus BV
TickerMRUS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINNL0011606264

Show aggregate MRUS holdings

News associated with MRUS

Merus N.V. (NASDAQ:MRUS) Receives Average Recommendation of “Buy” from Analysts
Merus N.V. (NASDAQ:MRUS – Get Free Report) has received an average recommendation of “Buy” from the twelve research firms that are covering the firm, Marketbeat.com reports. Eleven analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokerages that […] - 2025-09-04 03:06:58
Merus (NASDAQ:MRUS) Coverage Initiated at Alliance Global Partners
Research analysts at Alliance Global Partners started coverage on shares of Merus (NASDAQ:MRUS – Get Free Report) in a research note issued on Monday, MarketBeat reports. The firm set a “buy” rating and a $90.00 price target on the biotechnology company’s stock. Alliance Global Partners’ target price suggests a potential upside of 34.61% from the […] - 2025-08-27 02:30:45
Leerink Partnrs Estimates Merus’ Q3 Earnings (NASDAQ:MRUS)
Merus N.V. (NASDAQ:MRUS – Free Report) – Analysts at Leerink Partnrs dropped their Q3 2025 EPS estimates for Merus in a report issued on Wednesday, August 6th. Leerink Partnrs analyst A. Berens now forecasts that the biotechnology company will post earnings per share of ($1.50) for the quarter, down from their prior estimate of ($1.32). […] - 2025-08-12 02:46:48
Merus (NASDAQ:MRUS) Downgraded to Sell Rating by Wall Street Zen
Merus (NASDAQ:MRUS – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Sunday. A number of other research analysts have also issued reports on the company. Needham & Company LLC reiterated a “buy” rating and set a $75.00 […] - 2025-07-22 02:07:06
Wall Street Zen Upgrades Merus (NASDAQ:MRUS) to “Hold”
Merus (NASDAQ:MRUS – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday. A number of other brokerages have also issued reports on MRUS. William Blair reaffirmed an “outperform” rating on shares of Merus in a research report on […] - 2025-07-14 03:40:50
Insider Selling: Merus N.V. (NASDAQ:MRUS) COO Sells $1,793,840.00 in Stock
Merus N.V. (NASDAQ:MRUS – Get Free Report) COO Peter B. Silverman sold 34,000 shares of the firm’s stock in a transaction dated Friday, June 20th. The shares were sold at an average price of $52.76, for a total value of $1,793,840.00. The sale was disclosed in a legal filing with the SEC, which is accessible […] - 2025-06-27 05:10:52
Merus N.V. (NASDAQ:MRUS) Receives $84.64 Average Price Target from Brokerages
Merus N.V. (NASDAQ:MRUS – Get Free Report) has been assigned a consensus rating of “Buy” from the fourteen analysts that are currently covering the firm, MarketBeat reports. Twelve equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 1-year target price […] - 2025-06-24 02:36:57
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 14,544 Shares of Merus (NASDAQ:MRUS)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Merus (NASDAQ:MRUS – Free Report) by 17.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 98,744 shares of the biotechnology company’s stock after purchasing an additional 14,544 shares […] - 2025-06-05 05:13:00
Merus Prices 5.26 Mln Shares At $57/Shr In Public Offering; To Raise Around $300 Mln
(RTTNews) - Merus N.V. (MRUS), a Dutch oncology company developing multispecific antibodies and antibody drug conjugates, Wednesday announced the pricing of an underwritten public offering of around 5.26 million shares, at a price of $57.00 per share. The gross proceeds from the - 2025-06-04 01:56:43
Merus N.V. Announces Pricing of $300 Million Public Offering of Common Shares
Merus N.V. announced a $300 million public offering of 5.26 million common shares to fund clinical development and research. - 2025-06-04 01:20:22
Analysts Anticipate 25% Gains Ahead For The Holdings of FHLC
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-29 08:03:59
Merus (NASDAQ:MRUS) Earns Buy Rating from Needham & Company LLC
Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Needham & Company LLC in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $75.00 target price on the biotechnology company’s stock. Needham & Company LLC’s price target points to a potential upside […] - 2025-05-21 03:03:18
Merus (NASDAQ:MRUS) Holdings Decreased by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company reduced its stake in shares of Merus (NASDAQ:MRUS – Free Report) by 17.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,085 shares of the biotechnology company’s stock after selling 9,204 shares during the quarter. […] - 2025-05-12 05:36:50
Tudor Investment Corp ET AL Purchases Shares of 5,075 Merus (NASDAQ:MRUS)
Tudor Investment Corp ET AL bought a new stake in Merus (NASDAQ:MRUS – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 5,075 shares of the biotechnology company’s stock, valued at approximately $213,000. A number of other institutional investors and hedge […] - 2025-05-11 05:44:52
Tower Research Capital LLC TRC Decreases Stock Holdings in Merus (NASDAQ:MRUS)
Tower Research Capital LLC TRC decreased its stake in shares of Merus (NASDAQ:MRUS – Free Report) by 77.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,668 shares of the biotechnology company’s stock after selling 9,221 shares during the […] - 2025-05-09 05:21:09
Merus (NASDAQ:MRUS) Short Interest Update
Merus (NASDAQ:MRUS – Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 6,270,000 shares, a decrease of 15.5% from the March 31st total of 7,420,000 shares. Currently, 9.6% of the company’s shares are sold short. Based on […] - 2025-05-05 04:58:56
Merus (NASDAQ:MRUS) Earns “Outperform” Rating from William Blair
William Blair reaffirmed their outperform rating on shares of Merus (NASDAQ:MRUS – Free Report) in a report issued on Monday morning,RTT News reports. Several other analysts have also commented on the stock. Guggenheim reissued a “buy” rating and set a $109.00 target price on shares of Merus in a research note on Friday, March 28th. […] - 2025-04-29 04:54:48
Invesco Ltd. Grows Stock Position in Merus (NASDAQ:MRUS)
Invesco Ltd. lifted its holdings in Merus (NASDAQ:MRUS – Free Report) by 2.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 786,365 shares of the biotechnology company’s stock after purchasing an additional 16,712 shares during the period. Invesco Ltd. owned about 1.15% of Merus […] - 2025-04-18 05:18:50
HighTower Advisors LLC Has $337,000 Stock Position in Merus (NASDAQ:MRUS)
HighTower Advisors LLC lifted its position in Merus (NASDAQ:MRUS – Free Report) by 10.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,020 shares of the biotechnology company’s stock after buying an additional 789 shares during the period. HighTower […] - 2025-04-02 04:14:47
Guggenheim Reiterates Buy Rating for Merus (NASDAQ:MRUS)
Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Guggenheim in a report issued on Tuesday,Benzinga reports. They presently have a $109.00 target price on the biotechnology company’s stock. Guggenheim’s price objective indicates a potential upside of 131.91% from the company’s previous close. Other research analysts also recently […] - 2025-03-20 04:55:00
Bank of America Has Lowered Expectations for Merus (NASDAQ:MRUS) Stock Price
Merus (NASDAQ:MRUS – Get Free Report) had its target price lowered by analysts at Bank of America from $73.00 to $70.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Bank of America‘s price objective indicates a potential upside of 47.12% from the […] - 2025-03-12 04:00:48
HC Wainwright Reaffirms “Buy” Rating for Merus (NASDAQ:MRUS)
Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $85.00 price objective on the biotechnology company’s stock. HC Wainwright’s price target would suggest a potential upside of 90.41% from the stock’s previous close. […] - 2025-03-05 04:32:51
William Blair Predicts Merus’ FY2028 Earnings (NASDAQ:MRUS)
Merus (NASDAQ:MRUS – Free Report) – William Blair issued their FY2028 EPS estimates for Merus in a report issued on Friday, February 28th. William Blair analyst M. Phipps expects that the biotechnology company will post earnings per share of ($3.58) for the year. William Blair has a “Outperform” rating on the stock. The consensus estimate […] - 2025-03-04 06:28:57
Merus (NASDAQ:MRUS) Given New $83.00 Price Target at Needham & Company LLC
Merus (NASDAQ:MRUS – Free Report) had its price objective lowered by Needham & Company LLC from $85.00 to $83.00 in a research note released on Friday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. A number of other equities analysts have also recently commented on the company. The Goldman […] - 2025-03-03 04:54:51
Merus (NASDAQ:MRUS) Shares Purchased by State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D grew its holdings in shares of Merus (NASDAQ:MRUS – Free Report) by 29.0% during the 4th quarter, HoldingsChannel reports. The firm owned 48,268 shares of the biotechnology company’s stock after buying an additional 10,842 shares during the period. State of New Jersey Common Pension Fund D’s holdings […] - 2025-02-24 06:42:49
Analysts Set Merus (NASDAQ:MRUS) PT at $85.92
Shares of Merus (NASDAQ:MRUS – Get Free Report) have been assigned a consensus recommendation of “Buy” from the sixteen research firms that are covering the stock, MarketBeat reports. Fourteen equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average twelve-month price […] - 2025-02-19 04:46:55
KBC Group NV Has $2.41 Million Stake in Merus (NASDAQ:MRUS)
KBC Group NV raised its position in Merus (NASDAQ:MRUS – Free Report) by 4,583.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 57,234 shares of the biotechnology company’s stock after purchasing an additional 56,012 shares during the quarter. KBC Group NV’s holdings in […] - 2025-02-02 07:28:57

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) MRUS holdings

DateNumber of MRUS Shares HeldBase Market Value of MRUS SharesLocal Market Value of MRUS SharesChange in MRUS Shares HeldChange in MRUS Base ValueCurrent Price per MRUS Share HeldPrevious Price per MRUS Share Held
2025-11-11 (Tuesday)49,021USD 4,680,525MRUS holding increased by 2941USD 4,680,5250USD 2,941 USD 95.48 USD 95.42
2025-11-10 (Monday)49,021MRUS holding increased by 125USD 4,677,584MRUS holding increased by 21218USD 4,677,584125USD 21,218 USD 95.42 USD 95.23
2025-11-07 (Friday)48,896USD 4,656,366MRUS holding increased by 3423USD 4,656,3660USD 3,423 USD 95.23 USD 95.16
2025-11-06 (Thursday)48,896MRUS holding increased by 125USD 4,652,943MRUS holding increased by 10919USD 4,652,943125USD 10,919 USD 95.16 USD 95.18
2025-11-05 (Wednesday)48,771USD 4,642,024MRUS holding increased by 6828USD 4,642,0240USD 6,828 USD 95.18 USD 95.04
2025-11-04 (Tuesday)48,771MRUS holding increased by 126USD 4,635,196MRUS holding increased by 24623USD 4,635,196126USD 24,623 USD 95.04 USD 94.78
2025-11-03 (Monday)48,645USD 4,610,573MRUS holding decreased by -3892USD 4,610,5730USD -3,892 USD 94.78 USD 94.86
2025-10-31 (Friday)48,645USD 4,614,465MRUS holding decreased by -9729USD 4,614,4650USD -9,729 USD 94.86 USD 95.06
2025-10-30 (Thursday)48,645MRUS holding increased by 630USD 4,624,194MRUS holding increased by 71892USD 4,624,194630USD 71,892 USD 95.06 USD 94.81
2025-10-29 (Wednesday)48,015MRUS holding increased by 792USD 4,552,302MRUS holding increased by 70839USD 4,552,302792USD 70,839 USD 94.81 USD 94.9
2025-10-28 (Tuesday)47,223USD 4,481,463MRUS holding increased by 14167USD 4,481,4630USD 14,167 USD 94.9 USD 94.6
2025-10-27 (Monday)47,223USD 4,467,296MRUS holding decreased by -13222USD 4,467,2960USD -13,222 USD 94.6 USD 94.88
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MRUS by Blackrock for IE00BYXG2H39

Show aggregate share trades of MRUS

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY12595.44095.150 95.179USD 11,897 54.58
2025-11-06BUY12595.34095.020 95.052USD 11,881 54.16
2025-11-04BUY12695.08094.760 94.792USD 11,944 53.74
2025-10-30BUY63095.06094.850 94.871USD 59,769 53.09
2025-10-29BUY79294.81095.300 95.251USD 75,439 52.87
2025-10-22SELL-49694.40094.750 94.715USD -46,979 51.75 Loss of -21,313 on sale
2025-10-20BUY24894.44094.840 94.800USD 23,510 51.28
2025-10-17BUY62094.89095.040 95.025USD 58,916 51.04
2025-10-15BUY99294.95094.960 94.959USD 94,199 50.80
2025-10-03BUY86894.29094.350 94.344USD 81,891 50.31
2025-10-02BUY12494.15094.390 94.366USD 11,701 50.06
2025-09-30BUY24894.15094.295 94.280USD 23,382 49.56
2025-09-26BUY24868.89069.510 69.448USD 17,223 49.19
2025-09-25BUY24868.10068.550 68.505USD 16,989 49.09
2025-09-24BUY1,56168.25069.940 69.771USD 108,913 48.97
2025-09-18BUY11968.95069.610 69.544USD 8,276 48.86
2025-09-17BUY36068.17569.625 69.480USD 25,013 48.74
2025-08-20SELL-48064.43064.460 64.457USD -30,939 48.33 Loss of -7,741 on sale
2025-07-30BUY48066.16067.240 67.132USD 32,223 47.68
2025-07-17SELL-24061.44061.530 61.521USD -14,765 46.69 Loss of -3,559 on sale
2025-07-16BUY49956.50556.770 56.744USD 28,315 46.63
2025-07-11SELL-94454.50055.230 55.157USD -52,068 46.45 Loss of -8,216 on sale
2025-07-07BUY35452.58053.900 53.768USD 19,034 46.25
2025-07-02BUY6,49053.33054.180 54.095USD 351,077 46.15
2025-06-20BUY1,05153.10553.310 53.290USD 56,007 46.10
2025-06-11BUY23055.05057.000 56.805USD 13,065 45.69
2025-06-10BUY23056.45057.360 57.269USD 13,172 45.61
2025-06-04SELL-11557.58058.940 58.804USD -6,762 45.28 Loss of -1,555 on sale
2025-04-23BUY11541.83045.900 45.493USD 5,232 45.06
2025-04-10SELL-92038.62039.240 39.178USD -36,044 45.34 Profit of 5,669 on sale
2025-04-08SELL-11534.89039.490 39.030USD -4,488 45.53 Profit of 747 on sale
2025-04-07SELL-11537.39037.620 37.597USD -4,324 45.62 Profit of 923 on sale
2025-04-04SELL-57538.11040.690 40.432USD -23,248 45.71 Profit of 3,034 on sale
2025-04-01BUY1,01539.60042.438 42.154USD 42,787 45.82
2025-03-31SELL-33942.09045.440 45.105USD -15,291 45.86 Profit of 256 on sale
2025-03-21BUY1,76947.24048.720 48.572USD 85,924 45.84
2025-03-14SELL-1,71247.10049.250 49.035USD -83,948 45.74 Loss of -5,638 on sale
2025-03-07SELL-21446.07047.210 47.096USD -10,079 45.61 Loss of -317 on sale
2025-03-04SELL-10744.64045.280 45.216USD -4,838 45.61 Profit of 42 on sale
2025-02-25BUY21444.40046.700 46.470USD 9,945 45.60
2025-02-19SELL-10745.07045.180 45.169USD -4,833 45.52 Profit of 37 on sale
2025-02-13BUY32140.30041.145 41.061USD 13,180 45.90
2025-02-12BUY10740.26040.450 40.431USD 4,326 46.01
2025-02-11BUY42840.11040.660 40.605USD 17,379 46.14
2024-12-30SELL-3,67041.89042.385 42.335USD -155,371 48.41 Profit of 22,283 on sale
2024-11-18SELL-1,75544.27046.820 46.565USD -81,722 52.22 Profit of 9,917 on sale
2024-11-08SELL-11754.50054.900 54.860USD -6,419 52.09 Loss of -324 on sale
2024-10-21SELL-11751.60052.430 52.347USD -6,125 0.00 Loss of -6,125 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRUS

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19123,75515,565295,32441.9%
2025-09-1897,3164,160228,73742.5%
2025-09-17144,3271,098242,46559.5%
2025-09-16109,9602,131222,43449.4%
2025-09-15149,8900318,67947.0%
2025-09-12313,4555,537606,03651.7%
2025-09-11186,04117,755345,08153.9%
2025-09-1077,2990149,18451.8%
2025-09-09109,27712,250231,07547.3%
2025-09-08110,3000207,99053.0%
2025-09-05113,7432,003270,19242.1%
2025-09-0471,3900194,43536.7%
2025-09-03118,2361,764269,03743.9%
2025-09-02104,542485304,73834.3%
2025-08-2988,408602208,72042.4%
2025-08-28205,6791,769570,45436.1%
2025-08-2743,7270107,17140.8%
2025-08-2649,2210280,42017.6%
2025-08-2551,1610113,71745.0%
2025-08-22100,1567,575192,11152.1%
2025-08-2172,4115,956216,04233.5%
2025-08-2059,6600265,38522.5%
2025-08-1994,8490242,81639.1%
2025-08-1849,3072,689113,53643.4%
2025-08-1564,98410,335112,73357.6%
2025-08-1476,8440278,92427.6%
2025-08-13178,5061,001423,47642.2%
2025-08-1286,7181,133254,30134.1%
2025-08-1184,695390117,68072.0%
2025-08-08112,4221,666230,83448.7%
2025-08-07130,196179222,63858.5%
2025-08-06255,4360409,27962.4%
2025-08-05102,3195,000286,82235.7%
2025-08-0443,196067,78863.7%
2025-08-01111,3330277,02240.2%
2025-07-31164,449300435,71737.7%
2025-07-30114,7390179,11064.1%
2025-07-2969,9870152,83345.8%
2025-07-28117,8630253,63746.5%
2025-07-25170,5300303,99956.1%
2025-07-24254,6644,904482,53052.8%
2025-07-23145,1700217,50366.7%
2025-07-22139,563525302,77646.1%
2025-07-21287,1341,374573,96150.0%
2025-07-18269,9230465,09658.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.